Prospective randomized trial to compare accelerated (six fractions a week) radiotherapy against concurrent chemoradiotherapy (using conventional fractionation) in locally advanced head and neck cancers

Journal of Cancer Research and Therapeutics
Manoj GuptaTapesh Bhattacharyya

Abstract

Concurrent chemoradiation (CCRT) is currently considered to be the standard of care in locally advanced head and neck cancer. The optimum radiotherapy schedule for best local control and acceptable toxicity is not yet clear. We aimed at shortening of treatment time by using accelerated radiation, thereby comparing the disease response, loco-regional tumor control and tolerability of accelerated radiation (six fractions per week) against CCRT in locally advanced head and neck cancer. We conducted the prospective randomized study for a period of 2 years from June 2011 to May 2013 in 133 untreated patients of histologically confirmed squamous cell carcinoma of head and neck. Study group (66 patients) received accelerated radiotherapy with 6 fractions per week (66Gy/33#/5½ weeks). Control group (67 patients) received CCRT with 5 fractions per week radiation (66 Gy/33#/6½ weeks) along with intravenous cisplatin 30 mg/m(2) weekly. Tumor control, survival, acute and late toxicities were assessed. Median overall treatment time was 38 days and 45 days in the accelerated radiotherapy and concurrent chemoradiation arm, respectively. At a median follow up of 12 months, 41 patients (62.1%) in the accelerated radiotherapy arm and 47 patients...Continue Reading

References

Jan 15, 1997·International Journal of Radiation Oncology, Biology, Physics·M Stuschke, H D Thames
Mar 24, 1998·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·M BaumannK K Ang
Jun 16, 2001·Head & Neck·G P BrowmanUNKNOWN Cancer Care Ontario Practice Guideline Initiative Head and Neck Cancer Disease Site Group
Dec 31, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David J AdelsteinArlene A Forastiere
Dec 3, 2003·The New England Journal of Medicine·Arlene A ForastiereJay Cooper
Sep 5, 2006·Lancet·Jean BourhisUNKNOWN Meta-Analysis of Radiotherapy in Carcinomas of Head and neck (MARCH) Collaborative Group
Sep 11, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joseph K SalamaEverett E Vokes
May 19, 2009·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Jean-Pierre PignonUNKNOWN MACH-NC Collaborative Group
Jun 12, 2013·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Anupam RishiSuresh C Sharma

❮ Previous
Next ❯

Citations

Apr 9, 2017·Journal of Medical Case Reports·N-A Ouédraogo NdeA Lamien/Sanou

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.